The WACC of Cosmo Pharmaceuticals NV (COPN.SW) is 5.1%.
| Range | Selected | |
| Cost of equity | 3.80% - 6.40% | 5.10% |
| Tax rate | 14.60% - 20.40% | 17.50% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 3.8% - 6.4% | 5.1% |
| Category | Low | High |
| Long-term bond rate | 1.0% | 1.5% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.55 | 0.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 3.80% | 6.40% |
| Tax rate | 14.60% | 20.40% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 3.8% | 6.4% |
| Selected WACC | 5.1% | |